Carter Rick, Holiday David B, Nwasuruba Chiagozie, Stocks James, Grothues Carol, Tiep Brian
University of Texas Health Center at Tyler, 75708, USA.
Chest. 2003 May;123(5):1408-15. doi: 10.1378/chest.123.5.1408.
The 6-min walk (6MW) test is commonly used to assess exercise capacity in patients with COPD and to track functional change resulting from disease progression or therapeutic intervention. Not surprisingly, distance covered has been the preferred outcome for this test. However, distance walked does not account for differences in body weight that are known to influence exercise capacity.
The aim of this study was to evaluate the 6-min distance x body weight product (6MWORK) as an improved outcome measure with a solid physiologic foundation.
One hundred twenty-four men and women with moderate-to-severe COPD volunteered and completed the testing sequence, which included pulmonary function, a peak effort ramp cardiopulmonary exercise study with gas exchange, and the 6MW. Means and SD were generated for the variables of interest. Differences were analyzed using analysis of variance techniques. Correlation coefficients and receiver operating characteristic (ROC) curves were calculated for the 6-min walk distance (6MWD) and 6MWORK with indexes of pulmonary function, work performance, and Borg scores for dyspnea and effort.
Men and women presented with a significant smoking history that also differed by gender (48 vs 66 pack-years, respectively; p < 0.01). The mean (+/- SD) FEV(1) values were 45 +/- 12.6% and 48 +/- 12.1%, respectively (not significant), while the diffusing capacity of the lung for carbon monoxide (DLCO) was 14.7 +/- 6.1 vs 10.3 +/- 3.9 mL/min/mm Hg, respectively (p < 0.001), for men and women. The 6MWD averaged 416.8 +/- 79.0 m for men and 367.8 +/- 78.6 m for women, and these differences were significant (p < 0.002). When 6MWD was compared as the percent predicted of normal values, each gender presented with a similar reduction of 78.6 +/- 14.5% vs 79.9 +/- 17.5% (p > 0.05), respectively. 6MWORK averaged 35,370 +/- 9,482 kg/m and 25,643 +/- 9,080 kg/m (p < 0.0001) for men and women, respectively. 6MWORK yielded higher correlation coefficients than did 6MWD when correlated with DLCO, lung diffusion for alveolar ventilation, FEV(1), FEV(1)/FVC ratio, watts, peak oxygen uptake, peak minute ventilation, and peak tidal volume. The ROC curve demonstrated that 6MWORK had a significantly larger calculated area under the curve (p < 0.05) [plot of 100-sensitivity to specificity for each variable of interest for all subjects] than 6MWD when differentiating an objectively selected definition of low work capacity vs high work capacity (bike ergometry work, < 55 vs > 55 W, respectively).
We conclude that work calculated as the product of distance x body weight is an improved outcome measure for the 6MW. 6MWORK can be used whenever the 6MW is required to estimate a patient's functional capacity. This measure is also a common measure, which can be converted to indexes of caloric expenditure for direct cross-modality comparisons.
6分钟步行(6MW)试验常用于评估慢性阻塞性肺疾病(COPD)患者的运动能力,并追踪疾病进展或治疗干预导致的功能变化。不出所料,该试验中行走的距离一直是首选的结果指标。然而,行走的距离并未考虑已知会影响运动能力的体重差异。
本研究的目的是评估6分钟距离×体重乘积(6MWORK)作为一种具有坚实生理基础的改进结果指标。
124名中重度COPD男性和女性志愿者完成了测试序列,包括肺功能、带有气体交换的最大运动强度斜坡心肺运动研究以及6MW试验。计算了感兴趣变量的均值和标准差。使用方差分析技术分析差异。计算了6分钟步行距离(6MWD)和6MWORK与肺功能指标、工作表现以及呼吸困难和用力程度的Borg评分之间的相关系数和受试者工作特征(ROC)曲线。
男性和女性都有显著的吸烟史,且性别之间也存在差异(分别为48与66包年;p < 0.01)。男性和女性的平均(±标准差)第一秒用力呼气容积(FEV₁)值分别为45±12.6%和48±12.1%(无显著差异),而男性和女性的肺一氧化碳弥散量(DLCO)分别为14.7±6.1与10.3±3.9 mL/min/mm Hg(p < 0.001)。男性的6MWD平均为416.8±79.0米,女性为367.8±78.6米,这些差异具有统计学意义(p < 0.002)。当将6MWD作为预测正常值的百分比进行比较时,男性和女性的下降比例相似,分别为78.6±14.5%与79.9±17.5%(p > 0.05)。男性和女性的6MWORK平均分别为35370±9482千克·米和25643±9080千克·米(p < 0.0001)。当与DLCO、肺泡通气的肺弥散、FEV₁、FEV₁/FVC比值、瓦特数、峰值摄氧量、峰值分钟通气量和峰值潮气量相关时,6MWORK产生的相关系数高于6MWD。ROC曲线表明,在区分客观选择定义的低工作能力与高工作能力(自行车测力计工作,分别< 55与> 55瓦)时,6MWORK的曲线下计算面积显著大于6MWD(p < 0.05)[针对所有受试者的每个感兴趣变量绘制100 - 敏感度对特异度的图]。
我们得出结论,将距离×体重的乘积计算得出的工作量是6MW试验的一种改进结果指标。每当需要6MW试验来估计患者的功能能力时,都可以使用6MWORK。该指标也是一种常用指标,可转换为热量消耗指标以进行直接的跨模式比较。